AstraZeneca To Invest $50 Bn In The US As Tariff Threat Looms
The funds will boost its manufacturing and research operations in the US, including the construction of a multi-billion-dollar factory in Virginia, the company said in a statement.
"Today's announcement underpins our belief in America's innovation in biopharmaceuticals," chief executive Pascal Soriot said in a statement.
US President Donald Trump has opened the door to potential tariffs targeting pharmaceuticals, which had up to now benefited from exemptions to his sweeping levies on imports from trading partners.
He ordered an investigation into pharmaceutical imports, suggesting that levies could reach up to 200 percent.
The United States is a key market for the pharmaceutical industry, and AstraZeneca said it expects 50 percent of its revenue to come from the US by 2030.
AstraZeneca has already begun transferring part of its European production to the United States, it announced in April.
While the drugmaker could become exposed to US levies on its European-made products, Soriot has said that the impact would be limited due to the ongoing shift in production.
Other major pharmaceutical companies, which had been exempt from tariffs for 30 years, have in recent months begun shifting investment and production to the United States.
Swiss pharmaceutical giants Roche and Novartis and France's Sanofi have all announced multi-billion-dollar investments in the US.
"For decades, Americans have been reliant on foreign supply of key pharmaceutical products," US Commerce Secretary Howard Lutnick said in a statement.
He added that the new tariffs are focused on "ending this structural weakness".
Tuesday's announcement included a new factory in Virginia, which will be the company's "largest single manufacturing investment".
It adds to AstraZeneca's previously announced $3.5 billion investment in the US by 2026.
"Soriot implied... that AstraZeneca wasn't wedded to a particular country and that it would invest wherever it made financial sense," said AJ Bell investment director Russ Mould.
However, he noted that "the more business it does in the country, the greater the likelihood that investors might push for AstraZeneca to switch its main stock listing to the US."
The pharmaceutical company abandoned plans earlier in the year to build a GBP450 million ($606 million) vaccine plant in the UK city of Liverpool, citing timing issues and a reduction in subsidies offered by the government.
The move "was the big clue that it was losing patience with the UK government," said Mould.
AstraZeneca reported a first-quarter profit rise of over 30 percent in April, noting that 40 percent of its revenue was generated in the US.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Int'l Business Times
an hour ago
- Int'l Business Times
Europe Hopes For 'No Surprises' As US Weighs Force Withdrawals
After keeping Donald Trump happy with a pledge to up defence spending at NATO's summit, Europe is now bracing for a key decision from the US president on the future of American forces on the continent. Washington is currently conducting a review of its military deployments worldwide -- set to be unveiled in coming months -- and the expectation is it will lead to drawdowns in Europe. That prospect is fraying the nerves of US allies, especially as fears swirl that Russia could look to attack a NATO country within the next few years if the war in Ukraine dies down. However, the alliance is basking in Trump's newfound goodwill following its June summit in The Hague, and his officials are making encouraging noises that Europe will not be left in the lurch. "We've agreed to no surprises and no gaps in the strategic framework of Europe," said Matthew Whitaker, US ambassador to NATO, adding he expected the review to come out in "late summer, early fall". "I have daily conversations with our allies about the process," he said. While successive US governments have mulled scaling back in Europe to focus more on China, Trump has insisted more forcefully than his predecessors that the continent should handle its own defence. "There's every reason to expect a withdrawal from Europe," said Marta Mucznik from the International Crisis Group. "The question is not whether it's going to happen, but how fast." When Trump returned to office in January many felt he was about to blow a hole in the seven-decade-old alliance. But the vibe in NATO circles is now far more upbeat than those desperate days. "There's a sanguine mood, a lot of guesswork, but the early signals are quite positive," one senior European diplomat told AFP, talking as others on condition of anonymity. "Certainly no panic or doom and gloom." The Pentagon says there are nearly 85,000 US military personnel in Europe -- a number that has fluctuated between 75,000 and 105,000 since Russia's 2022 invasion of Ukraine. "I think it is inevitable that they pull out some of their forces," a second European diplomat told AFP. "But I don't expect this to be like a dramatic overhaul. I think it's going to be gradual. I think it's going to be based on consultations." Trump's first target is likely to be the troops left over from a surge ordered by his predecessor Joe Biden after Moscow's tanks rolled into Ukraine. Officials say relocating the rump of that 20,000-strong deployment would not hurt NATO's deterrence too much -- but alarm bells would ring if Trump looked to cut too deep into personnel numbers or close key bases. The issue is not just troop numbers -- the US has capabilities such as air defences, long-range missiles and satellite surveillance that allies would struggle to replace in the short-term. "The kinds of defence investments by Europe that are being made coming out of The Hague summit may only be felt in real capability terms over many years," said Ian Lesser from the German Marshall Fund think tank. "So the question of timing really does matter." Washington's desire to pull back from Europe may be tempered by Trump now taking a tougher line with Russia -- and Moscow's reluctance to bow to his demands to end the Ukraine war. "It seems an inopportune moment to send signals of weakness and reductions in the American security presence in Europe," Lesser said. He also pointed to Trump's struggles during his first term to pull troops out of Germany -- the potential bill for relocating them along with political resistance in Washington scuppering the plan. While European diplomats are feeling more confident than before about the troop review, they admit nothing can be certain with the mercurial US president. Other issues such as Washington's trade negotiations with the EU could rock transatlantic ties in the meantime and upend the good vibes. "It seems positive for now," said a third European diplomat. "But what if we are all wrong and a force decrease will start in 2026. To be honest, there isn't much to go on at this stage."
Int'l Business Times
2 hours ago
- Int'l Business Times
Most Markets Rise, Euro Boosted After EU Strikes US Trade Deal
Most stock markets rose with the euro Monday after the European Union and United States hammered out the "biggest-ever" deal to avert a potentially damaging trade war. News of the deal, announced by Donald Trump and European Commission head Ursula von der Leyen on Sunday, followed US agreements last week, including with Japan, and comes ahead of a new round of China-US talks. Investors were also gearing up for a busy week of data, central bank decisions and earnings from some of the world's biggest companies. Trump and von der Leyen announced at his golf resort in Scotland that a baseline tariff of 15 percent would be levied on EU exports to the United States. "We've reached a deal. It's a good deal for everybody. This is probably the biggest deal ever reached in any capacity," Trump said, adding that the levies would apply across the board, including for Europe's crucial automobile sector, pharmaceuticals and semiconductors. Brussels also agreed to purchase "$750 billion worth of energy" from the United States, as well as make $600 billion in additional investments. "It's a good deal," von der Leyen said. "It will bring stability. It will bring predictability. That's very important for our businesses on both sides of the Atlantic." The news boosted the euro, which jumped to $1.1779 from Friday's close of $1.1749. And equities built on their recent rally, fanned by relief that countries were reaching deals with Washington. Hong Kong led winners, jumping around one percent, with Shanghai, Sydney, Seoul, Wellington, Taipei and Jakarta also up, along with European and US futures. Tokyo fell for a second day, having soared about five percent on Wednesday and Thursday in reaction to Japan's US deal. Singapore and Seoul were also lower. The broad gains came after another record day for the S&P 500 and Nasdaq on Wall Street. "The news flow from both the extension with China and the agreement with the EU is clearly market-friendly, and should put further upside potential into the euro... and should also put renewed upside into EU equities," said Chris Weston at Pepperstone. Traders are gearing up for a packed week, with a delegation including US Treasury Secretary Scott Bessent holding fresh trade talks with a Chinese team headed by Vice Premier He Lifeng in Stockholm. While both countries in April imposed tariffs on each other's products that reached triple-digit levels, US duties this year have temporarily been lowered to 30 percent and China's countermeasures slashed to 10 percent. The 90-day truce, instituted after talks in Geneva in May, is set to expire on August 12. Also on the agenda are earnings from tech titans Amazon, Apple, Meta Microsoft, as well as data on US economic growth and jobs. The Federal Reserve's latest policy meeting is expected to conclude with officials standing pat on interest rates, though investors are keen to see what their views are on the outlook for the rest of the year in light of Trump's tariffs and recent trade deals. The Bank of Japan is also forecast to hold off on any big moves on borrowing costs. Tokyo - Nikkei 225: DOWN 0.7 percent at 41,148.07 (break) Hong Kong - Hang Seng Index: UP 1.0 percent at 25,631.28 Shanghai - Composite: UP 0.3 percent at 3,602.97 Dollar/yen: UP at 147.74 yen from 147.68 yen on Friday Euro/dollar: UP at $1.1755 from $1.1738 Pound/dollar: UP at $1.3436 from $1.3431 Euro/pound: UP at 87.48 pence from 87.40 pence West Texas Intermediate: UP 0.5 percent at $65.48 per barrel Brent North Sea Crude: UP 0.5 percent at $68.80 per barrel New York - Dow: UP 0.5 percent at 44,901.92 (close) London - FTSE 100: DOWN 0.2 percent at 9,120.31 (close)
Int'l Business Times
2 hours ago
- Int'l Business Times
US Tariff Tussles Stuff Of Nightmares For Bordeaux Winemakers
French wine producers, already reeling from a downturn in their market, still do not know how bitter a taste the US tariffs on wine will leave on their palates. In southwestern France, around the Bordeaux region's famed vineyards, months of talk on what US President Donald Trump will decide on tariffs have been the stuff of nightmares for producers as they look on helplessly. The United States is by far the top export market for Bordeaux's wine, accounting for 400 million euros ($470 million) worth of annual sales -- or about 20 percent of the total. China lags behind with 300 million euros ahead of the United Kingdom with 200 million. Sunday's announcement of a trade deal between the United States and the European Union did not clear up what tariffs European wine and spirits producers will face in the United States. While Trump said European exports face 15 percent tariffs across the board, both sides said there would be carve-outs for certain sectors. EU head Ursula Von der Leyen said the bloc still hoped to secure further so-called "zero-for-zero" agreements, notably for alcohol, which she hoped to be "sorted out" in the coming days. Philippe Tapie, chairman of regional traders' union Bordeaux Negoce, which represents more than 90 percent of the wine trade in the Bordeaux area, is worried by the uncertainty. "One day, it is white, the next it is black -- the US administration can change its mind from one day to the next and we have no visibility," he told AFP. In mid-March, Trump had threatened Brussels with 200 percent tariffs on alcohol in response to a proposed EU tax on US bourbon. Then in April he brandished a new threat of 20 percent across the board on EU products, a threat ultimately suspended. Since then, the level first held at ten percent but, in late May, the US leader threatened to revert to 50 percent before pivoting to 30 percent starting August 1st, the deadline for the negotiations with the EU that led to a preliminary accord after Trump and Von der Leyen met in Scotland on Sunday. "At 10 percent or 15 percent, we'll find solutions. At 30 percent, no. End of story," Tapie warned just ahead of the announcement as he criticised a "totally unpredictable American administration". To export wine, "there's a minimum of 30 days by boat. If you go to California, it's 60 days. We can't think in terms of weeks," says Tapie, who says he has "never been confronted with such a situation" in 30 years of business. Twins Bordeaux, one of Bordeaux's leading wine merchants, also laments the tariffs' impact. "The American market represents about a third of our turnover, or around 30 million euros," explains Sebastien Moses, co-director and co-owner of Twins, which usually ships upwards of a million bottles a year to the United States. Since January, "our turnover must have fallen by 50 percent compared to last year," he says. "So far, we've managed to save the situation, because as soon as Donald Trump was elected we anticipated this and sent as much stock as possible to the US," explains Moses, though longer term he says this is not a "stable" strategy. As an attempted work around Twins Bordeaux even shipped cases of around 10,000 bottles by air in March. "But only very expensive wines, at no less than 150-200 euros per bottle, because by air it's at least two and a half times the price of shipping by sea," he said. For Bordeaux wine merchant Bouey, the US market represents less than 10 percent of its exports. "We have long since undertaken a geographical expansion. Faced with the global chaos, commercial strategies can no longer be based on a single- or dual-country strategy," Jacques Bouey, its CEO, told AFP in April. The tariffs come with the industry already struggling with declining consumption that has led to overproduction and a collapse in bulk prices. By early 2023, a third of Bordeaux's approximately 5,000 wine growers admitted to being in difficulty. "We're starting to become world champions in terms of accumulating problems," complained Tapie.
